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Abstract
Background: Adhesions formation is a significant postsurgical complication. At present, there is no effective
method for preventing adhesions formation [1], although barrier products such as Dextran (Dex) [2] and sodium
hyaluronate (SH) [3] have proved the most clinically successful [4-6], This study is designed to investigate the
preventive and therapeutic potential of a novel penicillamine-bound membrane for abdominal adhesions
formation.
Methods: 150 rats were involved in the present study. All animals were randomly divided into 6 groups (1 vehicle
group and 5 test groups respectively treated with dextran, sodium hyaluronate, penicillamine, penicillamine-bound
membrane or non-penicillamine-bound membrane). The occurrence, grade and score of abdominal adhesions
were compared between the different groups. The breaking strength of incision was compared between the
vehicle group and the penicillamine, membrane with/without penicillamine - treated groups. Expression of
collagen type I was compared between the vehicle and penicillamine-treated group. The occurrence of adhesions
was compared between the Dextran (Dex), sodium hyaluronate (SH), penicillamine-treated group and membrane
with or without penicillamine- treated groups.
Results: Penicillamine and penicillamine-bound membrane had significant preventive effects on abdominal
adhesions formation, better than dextran, sodium hyaluronate and non-penicillamine-bound membrane. However,
neither of them influenced incision healing, although they insignificantly decreased the breaking strength of the
incision. Penicillamine-bound membrane, which can be loaded locally and more efficaciously, shows greater
advantages than penicillamine.
Conclusions: Penicillamine-bound membrane can be applied as an effective therapeutic intervention for
abdominal adhesions with inconsequential side effects.
Background
Adhesions develop in over 90% of patients after abdom-
inal operations [3,7] and can lead to significant postsur-
gical complications, including small bowel obstruction,
infertility, chronic pelvic pain and difficult re-operative
surgeries [2,8]. Adhesions formation is a dynamic and
complex process, which involves a cascade of reactions
of cellular, biochemical, immunological and biomechani-
cal factors [9]. Unfortunately, there is no available
marker to predict the occurrence or severity of adhe-
sions preoperatively [10] and therapeutic prevention still
remains a challenge.
At present, the prevention of adhesions formation
after surgery has focused on minimizing peritoneal
trauma and reducing the implantation of foreign materi-
als into the peritoneal cavity, as they may aggravate the
inflammatory response [11-14]. Numerous approaches
have been attempted, including profibrinolytic agents
and physical barriers [3,15], such as Dextran (Dex) [2]
and sodium hyaluronate (SH) [3]. While the barrier pro-
ducts have been proven the most clinically successful
[4-6], there is no effective method of preventing adhe-
sions formation currently [1].
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Previously, penicillamine was reported to prevent
collagen fibers from crossing into non-soluble collagen
tissue and inhibit the maturation of dissoluble col-
lagen. Recent studies indicated the possibility of oral
D-penicillamine-induced prevention on peritoneal
adhesions band formation [16-18]. We therefore
hypothesized that it can prevent the fibrin from con-
verting into permanent fiber adhesions tissue. Hereby,
we developed a novel membrane, which is composed
of two regents- penicillamine and hyaluronic acid, and
then applied this penicillamine-bound membrane to
treat abdominal adhesions in an animal model, in
order to identify its preventive and therapeutic poten-
tial for adhesions formation.
Methods
Method for manufacturing novel penicillamine-bound
membrane
Chitosan [2](Shanghai Qisheng Biologic Agent Company),
or polylactic acid or hyaluronic acid [10](Center for New
Drug Evaluation, Shandong University) was individually
dissolved into saline at the concentration mentioned in
previous literatures. Penicillamine (Catalog number:
000108, Shanghai, PR China) was dissolved into three dif-
ferent solutions. The solutions were drained into the flat
bottom plastic container and dried thoroughly until poly-
merized. The thickness and dissolve time for the three dif-
ferent kinds of polymerized membranes were measured in
order to select the best substrate of penicillamine-bound
membrane. The release of penicillamine was defined by
dissolving the membranes into saline solution. Eventually,
hyaluronic acid was chosen for the substrate of penicilla-
mine-bound membrane. Hyaluronic acid and aluminum
chloride (at the concentration of 5%) were dissolved into
autoclaved PBS to make solution 1. Carboxymethyl Cellu-
lose was dissolved in double-distilled water (ddH2O) to
make solution 2. And then solution 1 and 2 were 1:1
mixed thoroughly. 2.5 ml of 10% penicillamine was
pipetted into 50 ml mixed solution in order to lead to
cross-linking between penicillamine and substrate. The
solutions were drained into the flat bottom plastic con-
tainer and dried thoroughly for 4-7 days until fully poly-
merized in air. The thickness of penicillamine-bound
membrane was about 0.1 mm, and the degradation of the
membrane cost 5 days in corpore. We tested the concen-
tration of penicillamine of the solution after the mem-
brane was dissolved into saline at a different time.
Animal model of abdominal adhesions
Total 150 rats (Wistar rats of both genders from ani-
mals facility of Shandong University) at 9 weeks of age,
weighing 200~230 g, were involved in the present study
with 25 animals per group in order to calculate the
occurrence of abdominal adhesions. The rats were
treated under the animal use guidelines of Institutional
Animal Care and Use Committee (IACUC) at Qilu Hos-
pital & College of Medicine, Shandong University. Rats
were allowed to adapt to the new environment for 1-
2 days prior to experimental study. The study was
approved by the ethics committee of Qilu Hospital,
Shandong University.
All animals were randomly divided into six groups (25
per group), including the vehicle group (A) and five
treated groups (B, C, D, E and F). All groups were
anesthetized with 10% chloral hydrate at the dosage of
300~350 mg/kg by intraperitoneal injection, and then
underwent abdominal surgery through midline incision
1.5 cm in length. The caecum serosa was scratched with
dry gauze at 2 cm × 2 cm [19] (Figure 1). One milliliter
saline was put into the rats’ abdominal cavity in group
A, while 1 ml 40% Dextran (Dex), 0.5 ml sodium hyalur-
onate (SH) (Shandong Zhengda Freda Tragacanth Com-
pany) and 1 ml 3% penicillamine for group B, C and D.
The scratched area on caecum serosa in group E was
covered by penicillamine-bound membrane (Figure 1),
and group F was covered by non-penicillamine-bound
membrane. The membrane was not fixed and adhered
to the scratched area naturally.
Tissue preparation
Half of the animals in each group (about 10 animals
for every group and time point) were sacrificed at
post-surgical day 7, while another half was sacrificed at
post-surgical day 14. The adhesions tissue inside the
abdominal cavity in different groups was removed and
stored in 4% paraformalhyde, then subjected to immu-
nohistochemistry staining. The incision, associated with
the lateral skin tissue in different groups, was sheared at
4×0.5 cm to test its breaking strength.
Measurement of adhesions degree and breaking strength
of incision
The occurrence of adhesions was calculated as the ratio
between animals with adhesions tissue and total animals
within that group (Table 1). The adhesions grade and
score in different groups were defined by Bigatti’s
method [20](Table 2). The breaking strength of incision
was measured by a strength-tester (See Additional file 1).
After removing the stitches from the incision tissue, it
was connected with a water container by a pulley and the
breaking strength was defined by the gravity of the water
(The Unit was gram), which was drained into the con-
tainer when the incision tissue was broken. All of these
measurements were performed by a blinded observer.
Immunohistochemistry
Slices (40 μm) were made from 4% paraformalhyde-fixed
adhesions tissue with a microtome, then transferred into
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0.1 M phosphate buffer (PB) (pH = 7.4). The slices were
incubated in 1:500-diluted polyclonal rabbit anti-
collagen type I (Beijing Biosynthesis Biotechnology Co.,
Ltd., China) at 4°C overnight, and then washed in 0.1 M
PB three times. Slices were then transferred into avidin-
biotin-peroxidase complex and incubated for 20 min at
37°C, then washed with 0.1 M PB, incubated with 3,
3-diaminobenzidine (DAB) tetrahydrochloride for 5-
15 min and washed three times in 0.1 M PB. Slices were
then mounted onto gelatin-treated slides, dried over-
night, and dehydrated serially with 50%, 70%, 95% etha-
nol once, and 100% ethanol and xylene twice. Slides
were then coverslipped using the mounting solution and
viewed under the microscope. Negative control experi-
ment was performed by applying 0.1 M PB solution as
the primary antibody.
Data analysis and statistics
The occurrence of adhesion was compared by Chi-
square test. The adhesion score, the breaking strength
of incision were compared between different groups
by one-way ANOVA with post hoc Tukey’s test. Data
was shown as percentage or mean ± SD. P< 0.05 was
considered statistically significant. Data analyses were
performed using SPSS statistical program version
16.0.
Results
Penicillamine prevents the abdominal adhesions
formation significantly
An animal model of abdominal adhesions was achieved
with a success rate of 88.33%. About 24 animals in total
died during surgery, about 4 animals per group for rea-
sons such as bleeding or overdose of anesthesia. Animal
death occurred across all groups, which could indicate no
potential toxicity of any of the compounds used. Dead
animals were discarded from our study. Additionally, our
experiments showed no significant difference in adhesion
occurrence and scores relating to the sex of the animal.
The occurrence of adhesions in group A and D was
summarized in Table 1. Compared to the control group,
the occurrence in group D was significantly lower at
postsurgical day 7 and 14 (P = 0.0326, P < 0.05).
Further, the adhesions score in group D was signifi-
cantly decreased 7 days or 14 days after the surgery,
compared to control level (P = 0.0064, P < 0.01). Immu-
nohistochemical staining showed that more collagen
fibers (Figure 2) and blood vessel hyperplasia (Figure 3)
Figure 1 Animal model of abdominal adhesion. Arrow in (A) shows the caecum of normal animals. (B) Shows that the caecum is scratched
with dry gauze at 2 cm × 2 cm, which is treated as the sham group. While the arrow in (C) shows that, the scratched caecum is covered with
penicillamine-bound membrane.
Table 1 Comparison of the occurrence of adhesion, adhesion score and breaking strength of incision between control
(A) and treated groups (B, C, D)















100% 100% 7.625 ± 2.92 9.25 ± 1.91 245.1 ± 16.51 323.13 ± 43.77
Dextran
(B)
48% 80% 2.9 ± 1.19* 4.625 ± 2.92 100.6 ± 20.02* 190.45 ± 38.33*
SH
(C)
56% 80% 3.5 ± 1.6* 5.25 ± 1.91 115.0 ± 15.5* 183.6 ± 20.0*
Penicillamine
(D)
40% 48% 2.7 ± 3.19* 2.5 ± 1.82* 198.0 ± 12.35 287.8 ± 11.09
(* means p < 0.05, compared to control level).
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were observed in group A than in group D (Figure 2 at
10×, and Figure 3 at 40×magnification).
Penicillamine has more preventive effects on abdominal
adhesions than dextran (Dex) and sodium hyaluronate
(SH)
Compared to group B and C, penicillamine decreased
the adhesions score in group D most significantly (P =
0.0326, P < 0.05). The occurrence of adhesions in group
D was significantly lower at postsurgical day 7 (40% for
D, 48% for B, 56% for C) and day 14 (48% for D, 80%
for B, 80% for C).
Penicillamine-bound membrane shows greater benefits in
therapeutic prevention of abdominal adhesions than
penicillamine
The carrier for the penicillamine must be stable, non-
toxic, non-irritating and not react with the drug. The
Chitosan dissolve in acid solution, which has irritation.
Nevertheless, the polylactic acid dissolve in organic sol-
vents (chloroform, acetone, e.g.) in which penicillamine
can’t dissolve. Penicillamine-bound membrane was
developed by using hyaluronic acid as the substrate. The
membrane was made by only natural hyaluronic acid,
which dissolved into the saline in 15 minutes, and so
penicillamine was released thoroughly from the mem-
brane. The new membrane was made by hyaluronic
acid, aluminum chloride and carboxymethyl cellulose,
which dissolved into the saline in 5 days. Penicillamine
has a more prolonged period of action.
The concentration of penicillamine in the membrane
is 1.501 ± 0.023 mg/cm2. The occurrence of abdominal
adhesions in the penicillamine-bound membrane-treated
group (40%) was significantly lower than control (100%),
penicillamine-treated groups (48%) and non-penicilla-
mine-treated groups (78%) (Table 1) on postsurgical day
14. Comparison of adhesions score (Table 1) showed a
significance between control and treated groups, indicat-
ing that both penicillamine and penicillamine-bound
membrane successfully prevented abdominal adhesions
formation, which was confirmed by morphological
observation (Figure 4). Moreover, penicillamine-bound
membrane showed better effects than penicillamine
itself and non-penicillamine-bound membrane (P =
0.0046, P < 0.01) (Table 3). Penicillamine-bound mem-
brane could be loaded directly and locally onto the trau-
matic area, contributing to its advantages in clinical
administration than penicillamine.





Adhesions essentially fell apart 1
Adhesions lysed with traction 2
Adhesions required sharp dissection 3
Type
None 0
Filmy, no vessels (transparent) 1
Dense, no vessels (translucent) 2
Dense, vascular, small vessels (diameter 50 μm) 3
Dense, vascular, large vessels (diameter 50-110 μm) 4







Figure 2 Comparison of adhesion formation in different groups by immunochemistry staining. Arrows in (A) and (B) show the stained
collagen I. Significantly less collagen I and fibers are found in penicillamine-treated group (B) than in the sham group (A).
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Penicillamine and penicillamine-bound membrane did not
influence the incision healing, although they
insignificantly decreased the breaking strength of incision
Incision healing occurred very well in all groups. Com-
pared to postsurgical day 7, the breaking strength of
incision of each group was higher at postsurgical day 14.
Compared to group A, the breaking strength of incision
in group D, E and F were lower at postsurgical day 7 or
day 14. The possibility exists that tensile strength of the
abdominal wound might have been more affected if the
Figure 3 Comparison of wound healing in different groups by immunochemistry staining. Blood vessels hyperplasia is observed in the
sham group (A), while not in the penicillamine-treated group (B).
Figure 4 Comparison of adhesion formation in the sham and penicillamine-bound membrane-treated groups. Arrows in (A) and (B)
show that abdominal adhesion tissue is found in the sham group, while the adhesion is not found in the penicillamine-bound membrane-
treated group(C) and (D). Arrows in (C) and (D) show that the scratched caecum is recovered.
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membrane had been placed immediately deep to the
laparotomy incision. Penicillamine and penicillamine-
bound membrane did not influence the incision healing,
although they insignificantly decreased the breaking
strength of incision (Table 1, 3) (P > 0.05).
Discussion
Postsurgical abdominal adhesions have a great impact
on the quality of life of millions of people worldwide.
Small bowel obstruction and others complications of
adhesions are serious, causing not only morbidity but
also mortality [8,21]. Adhesions are non-anatomic con-
nections of fibrous tissue within normal peritoneal sur-
faces [7]. It may have a potential benefit, including
neovascularization of ischaemic structures such anasto-
moses, but it is also responsible for various clinical
problems [22].
The abdominal formation of fibrin is a common patho-
physiological pathway for adhesions. Fibrin is formed after
peritoneal injury, which can cause fibrinous adhesion. If
the fibrinolytic system, which results in lysis of abdominal
fibrin, is not activated, the adhesions will become fibrous
[23]. This can be explained when the equilibrium between
coagulation and fibrinolysis is disturbed [24-26]. Our pre-
sent study confirmed this by the evidence of more collagen
I fibers observed in the abdominal adhesions animal model
than in the vehicle group.
Apart from the formation of fibrin, a complex interac-
tion of biochemical components, including inflamma-
tion, fibrinolysis and wound healing, is involved in the
pathological process of abdominal adhesions [27]. For
instance, initially the deposition of fibrin is regulated
and maintained by growth factors and cytokines [28].
After the first week and up to a month, the matrix is
remodeled and replaced by persistent proteins, such as
collagen, and revascularization occurs. Fibrinolysis sti-
mulators, such as tissue plasminogen factor (t-PA), and
urokinase and fibrinolysis inhibitors, such as plasmino-
gen activator inhibitor type I (PAI-1), transforming
growth factor (TGF)-b, a key molecular mediator of
pathological fibrosis, have also been shown to play a
role in adhesions pathogenesis [29,30]. The interrela-
tionship between all the factors remains largely
unknown, therefore, identifying the effective treatment
or prevention for abdominal adhesions remains a big
challenge.
Numerous approaches have been used to prevent adhe-
sions [15]. The three main principle pathways are:
(1) decreasing the trauma to the peritoneum; (2) medical
intervention in the fibrin formation/degradation balance,
and (3) barriers (including fluid barrier and membranes)
preventing organs from bridging over to other structures
in the abdomen and thereby forming adhesions. Unfortu-
nately none of these measures have proven uniformly
effective under all surgical conditions. Barrier products,
including hyaluronic acid-carboxymethyl cellulose
membrane have been the most clinically successful in
reducing adhesions formation by preventing the close
apposition of injured tissues. However, treatment with
these products induced many side effects, such as post-
poning wound healing. Furthermore, many treated
models have a high standard deviation, which makes
the relevance of results with only moderate effects
questionable.
Penicillamine can decrease the permeability of vessels
by inhibiting aggregation of platelets, stabilizing lyso-
some and inhibiting releasing of lysomal enzymes. It can
also attenuate immune reaction and decrease blood disk
effusion and fibrin deposition by inhibiting generation of
IgG and IgM and decreasing antigen-antibody complex
in blood-serum, which blocks the first stage of abdom-
inal adhesions. It is reported that D-penicillamine
administration markedly reduces severe adhesions band
formation without severe side effects [18]. Therefore, we
hypothesized, based on these results, that a combination
of penicillamine and barrier products may be a better
treatment for adhesions.
In the present study, we developed a novel penicilla-
mine- bound membrane, which used hyaluronic acid as
the ideal substrate, and then found that both penicilla-
mine and penicillamine-bound membrane have better
therapeutic effects on preventing abdominal adhesions
than Dextran (Dex), sodium hyaluronate (SH) and non-
penicillamine-bound membrane. Both of them did
not affect wound healing. Although they decreased
the breaking strength of incision insignificantly at
Table 3 Comparison of occurrence of adhesion, adhesion score and breaking strength of incision between membranes
with/without penicillamine- treated groups















40% 40% 1.7 ± 1.45* 2.0 ± 1.6* 228.6 ± 19.97 331.7 ± 15.17
Non-Penicillamine -bound Membrane
(F)
80% 92% 7.1 ± 1.3 8.91 ± 2.32 259.4 ± 18.32 376.4 ± 23.43
(* means p < 0.05, compared to non-penicillamine -bound membrane- treated group)
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postsurgical day 7 but, this decrease was ameliorated at
postsurgical day 14. Penicillamine-bound membrane
showed greater benefits than penicillamine itself in pre-
ventive effects and local administration. Recent studies
investigated that penicillamine can inhibit blood vessel
hyperplasia[31], which plays an important role in adhe-
sions generation, by inhibiting the proliferation of
endangium and smooth muscle cell, and this was con-
firmed by our results.
Conclusions
The present research indicated that penicillamine-bound
membrane can be applied as an effective therapeutic
intervention for abdominal adhesion with inconsequen-
tial side effects, but further studies on the detailed
mechanisms for treating abdominal adhesion are still
warranted.
Additional material
Additional file 1: Test for breaking strength of incision. Step 1.
Connecting the incision with an empty water container. Step 2. Draining
thewater gradually into the container until the incision is broken, then
calculating the breaking strength by this formula (Breaking strength =
the gravity of total water).
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